Related references
Note: Only part of the references are listed.Smad4 Decreases the Population of Pancreatic Cancer-Initiating Cells through Transcriptional Repression of ALDH1A1
Yukari Hoshino et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Self-renewal and circulating capacities of metastatic hepatocarcinoma cells required for collaboration between TM4SF5 and CD44
Doohyung Lee et al.
BMB REPORTS (2015)
Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells
Monica Cojoc et al.
CANCER RESEARCH (2015)
All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells
Ming-Jer Young et al.
CARCINOGENESIS (2015)
Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species
T. Mizuno et al.
GYNECOLOGIC ONCOLOGY (2015)
Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma
Lili Yue et al.
MELANOMA RESEARCH (2015)
Notch Reporter Activity in Breast Cancer Cell Lines Identifies a Subset of Cells with Stem Cell Activity
Rosemarie C. D'Angelo et al.
MOLECULAR CANCER THERAPEUTICS (2015)
A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
Hovav Nechushtan et al.
ONCOLOGIST (2015)
Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling
Paola Marcato et al.
MOLECULAR ONCOLOGY (2015)
β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids
S. Condello et al.
ONCOGENE (2015)
Characterization and Propagation of Tumor Initiating Cells Derived from Colorectal Liver Metastases: Trials, Tribulations and a Cautionary Note
Mark I. James et al.
PLOS ONE (2015)
Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer
Maria A. Papadaki et al.
BMC CANCER (2014)
Hypoxia upregulates aldehyde dehydrogenase isoform 1 (ALDH1) expression and induces functional stem cell characteristics in human glioblastoma cells
Eric Soehngen et al.
BRAIN TUMOR PATHOLOGY (2014)
ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy
Y. Deng et al.
BRITISH JOURNAL OF CANCER (2014)
Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis
J. Yan et al.
BRITISH JOURNAL OF CANCER (2014)
Transforming growth factor-β1-induced epithelial-mesenchymal transition generates ALDH-positive cells with stem cell properties in cholangiocarcinoma
Ze-Yu Shuang et al.
CANCER LETTERS (2014)
The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
Debasish Raha et al.
CANCER RESEARCH (2014)
Aldehyde dehydrogenases in cancer: an opporunity for biomaker and drug development?
Klaus Pors et al.
DRUG DISCOVERY TODAY (2014)
Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase
Seung Ah Choi et al.
EUROPEAN JOURNAL OF CANCER (2014)
Characterization of a Novel Transgenic Mouse Tumor Model for Targeting HER2+Cancer Stem Cells
Su He Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
The Expression of Aldehyde Dehydrogenase Family in Breast Cancer
Yan Qiu et al.
JOURNAL OF BREAST CANCER (2014)
NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells
Di Zhao et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
The impact of Aldehyde dehydrogenase 1 expression on prognosis for metastatic colon cancer
Timothy L. Fitzgerald et al.
JOURNAL OF SURGICAL RESEARCH (2014)
ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma
Lang Yang et al.
MODERN PATHOLOGY (2014)
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer
Lorena Alonso-Alconada et al.
MOLECULAR CANCER (2014)
ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients
J. A. Ajani et al.
MOLECULAR ONCOLOGY (2014)
Multi-targeted inhibition of tumor growth and lung metastasis by redox-sensitive shell crosslinked micelles loading disulfiram
Xiaopin Duan et al.
NANOTECHNOLOGY (2014)
ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype
Ying Zhong et al.
MEDICAL ONCOLOGY (2014)
N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties
X. Qian et al.
ONCOGENE (2014)
Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
Jianqun Liao et al.
PLOS ONE (2014)
ALDH Maintains the Stemness of Lung Adenoma Stem Cells by Suppressing the Notch/CDK2/CCNE Pathway
Zhongjun Li et al.
PLOS ONE (2014)
ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling
Erhong Meng et al.
PLOS ONE (2014)
Identification of Tumor Endothelial Cells with High Aldehyde Dehydrogenase Activity and a Highly Angiogenic Phenotype
Hitomi Ohmura-Kakutani et al.
PLOS ONE (2014)
ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/β-catenin pathway
Julien Calderaro et al.
VIRCHOWS ARCHIV (2014)
Surface Markers of Cancer Stem Cells in Solid Tumors
Pu Xia
CURRENT STEM CELL RESEARCH & THERAPY (2014)
Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells of Breast Cancer Patients
Natalia Krawczyk et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Aldehyde Dehydrogenase1 Immunohistochemical Staining in Primary Breast Cancer Cells Independently Predicted Overall Survival But Did Not Correlate with the Presence of Circulating or Disseminated Tumors Cells
Wendy A. Woodward et al.
JOURNAL OF CANCER (2014)
Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
Suling Liu et al.
STEM CELL REPORTS (2014)
Recent Advances in the Molecular Characterization of Circulating Tumor Cells
Lori E. Lowes et al.
CANCERS (2014)
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination
Mario Giuliano et al.
BREAST CANCER RESEARCH (2014)
Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients
A. Giordano et al.
ANNALS OF ONCOLOGY (2013)
Inhibitory effect of Nodal on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma of uterus
Yi Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance
Radoslaw Januchowski et al.
BIOMEDICINE & PHARMACOTHERAPY (2013)
An integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancer
Jinping Jia et al.
BMC MEDICAL GENOMICS (2013)
ALDH1 expression is enriched in breast cancers arising in young women but does not predict outcome
E. Y. Tan et al.
BRITISH JOURNAL OF CANCER (2013)
Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells
S. Suman et al.
BRITISH JOURNAL OF CANCER (2013)
High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α
Ran-Ju Kim et al.
CANCER LETTERS (2013)
ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors
Cheng-Po Huang et al.
CANCER LETTERS (2013)
Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma
Wei Zhang et al.
CANCER LETTERS (2013)
β-Escin Inhibits NNK-Induced Lung Adenocarcinoma and ALDH1A1and RhoA/Rock Expression in A/J Mice and Growth of H460 Human Lung Cancer Cells
Jagan M. R. Patlolla et al.
CANCER PREVENTION RESEARCH (2013)
ALDH1-Positive Cancer Stem Cells Predict Engraftment of Primary Breast Tumors and Are Governed by a Common Stem Cell Program
Emmanuelle Charafe-Jauffret et al.
CANCER RESEARCH (2013)
Aldehyde dehydrogenases: From eye crystallins to metabolic disease and cancer stem cells
Vasilis Vasiliou et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2013)
Colon Cancer-Specific Cytochrome P450 2W1 Converts Duocarmycin Analogues into Potent Tumor Cytotoxins
Sandra Travica et al.
CLINICAL CANCER RESEARCH (2013)
Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
Daniel Guimaraes Tiezzi et al.
CLINICS (2013)
The Hitchhikers Guide to Cancer Stem Cell Theory: Markers, Pathways and Therapy
Akos Fabian et al.
CYTOMETRY PART A (2013)
Acquired resistance of leukemic cells to AraC is associated with the upregulation of aldehyde dehydrogenase 1 family member A2
Misaki Kawasoe et al.
EXPERIMENTAL HEMATOLOGY (2013)
Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization
Virginia Tirino et al.
FASEB JOURNAL (2013)
Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress
Surendra Singh et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
ALDH7A1 expression is associated with recurrence in patients with surgically resected non-small-cell lung carcinoma
Nicholas J. Giacalone et al.
FUTURE ONCOLOGY (2013)
MUC1-C Oncoprotein Activates ERK→C/EBPβ Signaling and Induction of Aldehyde Dehydrogenase 1A1 in Breast Cancer Cells
Maroof Alam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Neil E. Bhola et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Breast cancer as a systemic disease: a view of metastasis
A. J. Redig et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Re-engineering of the Duocarmycin Structural Architecture Enables Bioprecursor Development Targeting CYP1A1 and CYP2W1 for Biological Activity
Helen M. Sheldrake et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Antitumor Activity of a Duocarmycin Analogue Rationalized to Be Metabolically Activated by Cytochrome P450 1A1 in Human Transitional Cell Carcinoma of the Bladder
Mark Sutherland et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
Irene Baccelli et al.
NATURE BIOTECHNOLOGY (2013)
ALDH1-High Ovarian Cancer Stem-Like Cells Can Be Isolated from Serous and Clear Cell Adenocarcinoma Cells, and ALDH1 High Expression Is Associated with Poor Prognosis
Takafumi Kuroda et al.
PLOS ONE (2013)
Differential Effects of Drugs Targeting Cancer Stem Cell (CSC) and Non-CSC Populations on Lung Primary Tumors and Metastasis
Leyre Larzabal et al.
PLOS ONE (2013)
Prognostic Value of Cancer Stem Cell Marker Aldehyde Dehydrogenase in Ovarian Cancer: A Meta-Analysis
Shuyan Liu et al.
PLOS ONE (2013)
Reversing the Intractable Nature of Pancreatic Cancer by Selectively Targeting ALDH-High, Therapy-Resistant Cancer Cells
Sang Kyum Kim et al.
PLOS ONE (2013)
Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3
Ping Mao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Aldehyde dehydrogenase and ATP binding cassette transporter G2 (ABCG2) functional assays isolate different populations of prostate stem cells where ABCG2 function selects for cells with increased stem cell activity
Kalyan J. Gangavarapu et al.
STEM CELL RESEARCH & THERAPY (2013)
Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules
Bjorn L. Isfoss et al.
BMC CLINICAL PATHOLOGY (2013)
Unravelling cancer stem cell potential
Benjamin Beck et al.
NATURE REVIEWS CANCER (2013)
Loss of expression of the cancer stem cell marker aldehyde dehydrogenase 1 correlates with advanced-stage colorectal cancer
Crystal J. Hessman et al.
AMERICAN JOURNAL OF SURGERY (2012)
Doxorubicin-enriched, ALDHbr mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1
Xiufen Zhuang et al.
BMC CANCER (2012)
Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells
Alysha K. Croker et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells
P. Liu et al.
BRITISH JOURNAL OF CANCER (2012)
Metastatic Colonization Requires the Repression of the Epithelial-Mesenchymal Transition Inducer Prrx1
Oscar H. Ocana et al.
CANCER CELL (2012)
Spatiotemporal Regulation of Epithelial-Mesenchymal Transition Is Essential for Squamous Cell Carcinoma Metastasis
Jeff H. Tsai et al.
CANCER CELL (2012)
The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance
Jan S. Moreb et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2012)
The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors
Tobias Vogler et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2012)
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome
Xiao Li et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy
Thaer Khoury et al.
MODERN PATHOLOGY (2012)
Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer
Antonio Giordano et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma
Dong Liang et al.
MEDICAL ONCOLOGY (2012)
RhoC Impacts the Metastatic Potential and Abundance of Breast Cancer Stem Cells
Devin T. Rosenthal et al.
PLOS ONE (2012)
ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets
Yuchun Luo et al.
STEM CELLS (2012)
Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity
S. Akunuru et al.
CELL DEATH & DISEASE (2012)
Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical Application
Vindhya Koppaka et al.
PHARMACOLOGICAL REVIEWS (2012)
Integrin αv Expression Is Required for the Acquisition of a Metastatic Stem/Progenitor Cell Phenotype in Human Prostate Cancer
Christel van den Hoogen et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization
A. Gradilone et al.
ANNALS OF ONCOLOGY (2011)
STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH+/CD133+ stem cell-like human colon cancer cells
Li Lin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties
N. C. Yip et al.
BRITISH JOURNAL OF CANCER (2011)
Aldehyde dehydrogenase Its role as a cancer stem cell marker comes down to the specific isoform
Paola Marcato et al.
CELL CYCLE (2011)
Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity
Klaus Pors et al.
CHEMICAL COMMUNICATIONS (2011)
The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis
Christel van den Hoogen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Targeting ALDHbright Human Carcinoma-Initiating Cells with ALDH1A1-Specific CD8+ T Cells
Carmen Visus et al.
CLINICAL CANCER RESEARCH (2011)
Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44+CD24lo cancer stem cell phenotype
James M. Reuben et al.
EUROPEAN JOURNAL OF CANCER (2011)
Aldehyde dehydrogenase activity promotes survival of human muscle precursor cells
Elise Jean et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations
Xiaoli Chen et al.
JOURNAL OF HEPATOLOGY (2011)
The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells
Irene Ma et al.
STEM CELL REVIEWS AND REPORTS (2011)
Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells is Primarily Due to Isoform ALDH1A3 and Its Expression is Predictive of Metastasis
Paola Marcato et al.
STEM CELLS (2011)
Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-kappa B
Li Wei et al.
BREAST CANCER RESEARCH (2011)
Clinical relevance and biology of circulating tumor cells
Natalia Bednarz-Knoll et al.
BREAST CANCER RESEARCH (2011)
In Situ Identification of Putative Cancer Stem Cells by Multiplexing ALDH1, CD44, and Cytokeratin Identifies Breast Cancer Patients with Poor Prognosis
Veronique Neumeister et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
ALDHhigh adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis
Shuyang Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer
Panayiotis A. Theodoropoulos et al.
CANCER LETTERS (2010)
Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells In vitro and In vivo
Haijun Zhang et al.
CANCER RESEARCH (2010)
Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling
James P. Sullivan et al.
CANCER RESEARCH (2010)
High Aldehyde Dehydrogenase Activity Identifies Tumor-Initiating and Metastasis-Initiating Cells in Human Prostate Cancer
Christel van den Hoogen et al.
CANCER RESEARCH (2010)
Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs
Mario Cioce et al.
CELL CYCLE (2010)
Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
Emmanuelle Charafe-Jauffret et al.
CLINICAL CANCER RESEARCH (2010)
Retinoic acid directs neuronal differentiation of human pluripotent stem cell lines in a non-cell-autonomous manner
Peter D. Tonge et al.
DIFFERENTIATION (2010)
Activation of retinoic acid receptor signaling coordinates lineage commitment of spontaneously differentiating mouse embryonic stem cells in embryoid bodies
Zoltan Simandi et al.
FEBS LETTERS (2010)
Selection of Tumorigenic Melanoma Cells Using ALDH
Jim B. Boonyaratanakornkit et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose?
Malcolm R. Alison et al.
JOURNAL OF PATHOLOGY (2010)
Proteomic Identification of Paclitaxel-Resistance Associated hnRNP A2 and GDI 2 Proteins in Human Ovarian Cancer Cells
Dong Hyeon Lee et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma
Zeshaan A. Rasheed et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
All-trans retinoic acid promotes smooth muscle cell differentiation of rabbit bone marrow-derived mesenchymal stem cells
Zhong-yuan Su et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2010)
More than Markers: Biological Significance of Cancer Stem Cell-Defining Molecules
Stephen B. Keysar et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
Charles N. Landen et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity
Michael Rasper et al.
NEURO-ONCOLOGY (2010)
Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in melanoma
Brian W. Morrison et al.
MELANOMA RESEARCH (2010)
Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance
Kanya Honoki et al.
ONCOLOGY REPORTS (2010)
Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems
Boaz P. Levi et al.
BLOOD (2009)
Breast Cancer Metastasis: Challenges and Opportunities
J. Lu et al.
CANCER RESEARCH (2009)
Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis
Emina H. Huang et al.
CANCER RESEARCH (2009)
Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
Emmanuelle Charafe-Jauffret et al.
CANCER RESEARCH (2009)
Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
Tomonori Tanei et al.
CLINICAL CANCER RESEARCH (2009)
High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability
Alysha K. Croker et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Targeting aldehyde dehydrogenase: a potential approach for cell labeling
Ganesan Vaidyanathan et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Overcoming Drug Resistance in Patients with Metastatic Breast Cancer
Serena T. Wong et al.
PHARMACOTHERAPY (2009)
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Bahriye Aktas et al.
BREAST CANCER RESEARCH (2009)
Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily
Satori A. Marchitti et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the sera of patients with liver cancer
Wojciech Jelski et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2008)
ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells
Jan S. Moreb et al.
MOLECULAR CANCER (2008)
HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
H. Korkaya et al.
ONCOGENE (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells
Matthew J. Grimshaw et al.
BREAST CANCER RESEARCH (2008)
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
Christine M. Fillmore et al.
BREAST CANCER RESEARCH (2008)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
The combined use of Hoechst efflux ability and aldehyde dehydrogenase activity to identify murine and human hematopoietic stem cells
Daniel J. Pearce et al.
EXPERIMENTAL HEMATOLOGY (2007)
Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: A new paradigm for combination therapy in solid cancers
Georg Feldmann et al.
CANCER RESEARCH (2007)
Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity
Di Chen et al.
CANCER RESEARCH (2006)
Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells
John P. Chute et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity
Stefania Corti et al.
STEM CELLS (2006)
Inhibition of proteasome activity, nuclear factor-KB translocation and cell survival by the antialcoholism drug disulfiram
H Lövborg et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Impaired retinoic acid (RA) signal leads to RARβ2 epigenetic silencing and RA resistance
MQ Ren et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Retinoic acid down-regulates aldehyde dehydrogenase and increases cytotoxicity of 4-hydroperoxycyclophosphamide and acetaldehyde
JS Moreb et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity
L Armstrong et al.
STEM CELLS (2004)
Cu/Zn superoxide dismutase plays important role in immune response
M Marikovsky et al.
JOURNAL OF IMMUNOLOGY (2003)
Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram
SG Shiah et al.
MOLECULAR PHARMACOLOGY (2003)
Dissemination and growth of cancer cells in metastatic sites
AF Chambers et al.
NATURE REVIEWS CANCER (2002)
Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis
O Kitahara et al.
NEOPLASIA (2002)
Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer:: a retrospective study -: Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens
NE Sládek et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Cu/Zn superoxide dismutase plays a role in angiogenesis
M Marikovsky et al.
INTERNATIONAL JOURNAL OF CANCER (2002)